Zhejiang Peptites Biotech Co., Ltd. (abbreviated as ZPC below), founded in 2015,is a GMP factory that provides peptide APIs and cosmetic peptides. ZPC has rapidly grown into a leader in the field of peptides. As a national high-tech enterprise and a national-level "specialized, refined, characteristic, and innovative" small giant enterprise, the company has more than 900 employees and a large R&D team. ZPC is committed to the in-depth research, development, and innovation of peptide products, having obtained multiple ISO certifications and 110 patents.
In the field of R&D and production of APIs, ZPC has successfully launched more than 60 high-quality and high-value-added APIs using multiple independently developed core technologies. Products include Leuprolide Acetate, Liraglutide, Tirzepatide and Linaclotide, all adopt the company's unique synthesis and purification technology. At present, the annual production capacity of the company's peptides has reached tons, and the company is in the process of further expanding the production scale and improving production efficiency to meet the growing demand for high-quality APIs in both domestic and overseas markets. ZPC also offers CMO and CDMO services that provide one-stop solutions from R&D to production for global customers, helping them accelerate the process of launching new drugs to the market. In the future, ZPC will continue to deepen its commitment to the peptide API field, making even greater contributions to advancing global human health.
Main Competitive Advantages
International Approvals/Standards,Delivery Term,Large Product Line,Reputation,Quality Service
Website
http://english.peptide-china.com/